https://www.thebodypro.com/category/emtricitabine-emtriva-ftc

Emtricitabine (FTC, Emtriva)

The Latest

FDA Approves Generic Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg Img
Press Releases

FDA Approves Generic Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg

On June 8, 2017, the Food and Drug Administration approved the first generic version of emtricitabine and tenofovir disoproxil fumarate tablets, 200 mg/300 mg.

Switching to Emtricitabine/Tenofovir Alafenamide (F/TAF) Maintains Viral Suppression With Better Bone and Kidney Safety Img
CROI (Conference on Retroviruses and Opportunistic Infections)

Switching to Emtricitabine/Tenofovir Alafenamide (F/TAF) Maintains Viral Suppression With Better Bone and Kidney Safety

Switching from treatment regimens containing tenofovir/emtricitabine (Truvada, F/TDF) to regimens containing emtricitabine/tenofovir alafenamide (F/TAF) maintains undetectable viral loads and improves renal and bone safety, according to a CROI 2016 s...

Promo Image
News

Gilead and Tibotec Agree on New Single-Tablet Regimen

Gilead Sciences announced on November 15 that it has entered into a license agreement with Tibotec Pharmaceuticals for the development and commercialization of a single-tablet regimen combining Prezista (darunavir) with Gilead's Emtriva (emtricitabin...

Promo Image

Emtricitabine and Lamivudine May Be Similar, but Their Resistance Profiles Differ in Important Ways

Two of the most frequently prescribed components of combination therapy for HIV are the cytidine nucleoside reverse transcriptase inhibitors lamivudine (3TC, Epivir) and emtricitabine (FTC, Emtriva). They are nearly identical in atomic structure, alt...

Promo Image
News

Gilead, Royalty Pharma to Pay Emory University $525 Million for Rights to Emtricitabine

Emory University on Monday announced it will sell the rights to an antiretroviral drug developed by its scientists to Gilead Sciences and Royalty Pharma in exchange for a one-time payment of $525 million, the Atlanta Journal-Constitution reports (Wah...

Promo Image

No Difference Seen in Resistance Profiles of Emtricitabine and Lamivudine

Lamivudine (3TC, Epivir) and emtricitabine (FTC, Emtriva) are extremely similar drugs. In fact, emtricitabine is lamivudine with one fluorine in one of the rings of the product.

As you can see, emtricitabine (left) looks awfully similar to lamivudin...

Promo Image
News

Two New Fixed-Dose Combinations Approved

FDA announced approval today, August 2, 2004, of two fixed-dose combination (FDC) antiretroviral drug products for use with other antiretroviral agents for the treatment of HIV-1 infection. The FDCs are GlaxoSmithKline's EPZICOMTM (abacavir/lamivudin...

Promo Image

FTC Similar in Most Ways to 3TC

FTC (Emtricitabine, Emtriva) is the most recently approved HIV medication in the U.S. The drug is chemically similar to the often prescribed 3TC (lamivudine, Epivir) and can be dosed once daily (one pill) but has a longer chemical lifespan in the bod...

Promo Image

Phase III Results of FTC in Hepatitis B and HIV Co-Infected Patients

Anti-HBV Activity of Emtricitabine (FTC) in Patients Co-Infected With HIV and Hepatitis B Virus (Forum 215) Authored by F. Raffi, A. Snow, K. Borroto-Esoda, A. Shaw, J. Anderson, J. Sorbel, J. Quinn, E. Mondou, F. Rousseau

FTC (emtricitabine, ...

Promo Image

Comparison of Once-Daily FTC Vs. Twice-Daily Abacavir in a Regimen for Drug-Naive Patients

Once-Daily Emtricitabine Compared to Twice-Daily Abacavir Within a HAART Regimen in Antiretroviral Drug-Naive HIV-1-Infected Patients (ODECTA) (Poster 547) Authored by A.L. Shaw, G. Shen, C.W. Wakeford, J.B. Quinn, F.S. Rousseau

The recently a...